Zydus Lifesciences Ltd. Share Price
933.10 -2.65 (-0.28%)Zydus Lifesciences Limited is a global pharmaceutical company headquartered in Ahmedabad, India.
It is a leading player in the generics market and has been at the forefront of developing new and innovative pharmaceutical products.
It is a fully integrated company, with a presence in the research and development, manufacturing, marketing, and distribution of pharmaceutical products.
Business Segment
Zydus has three main business segments:
- Generics: includes a range of generic products, including oral formulations, injectable formulations, and topical formulations
- Specialty formulations: offers a range of specialty formulations that require specialized manufacturing, such as transdermal patches, controlled-release tablets, and sustained-release capsules
- Biologics: Biologics are complex products that are derived from living organisms. The pharma company develops a range of biologics, such as biosimilars and vaccines
- Product Portfolio: Cadabolic injection, Bilypsa tablets 4MG, Ampilox DS 500/500 MG, Fusys 150 MG Tablet 1, and ATEN 25 MG Tablet 14 among others
Geographical Presence
The company’s global business has a strong presence in the regulated markets of the US, Europe, and in the high-profile markets of Latin America and South Africa. It is also present in a big way in 25 other emerging markets worldwide.
Fundamentals
Market Cap
₹94,158CrEPS
₹44.97Book Value/Share
₹238.05P/E Ratio (TTM)
19.13Industry P/E (TTM)
41.20P/B Ratio
3.93Long Term D/E
0.13ROE
20.67%Dividend Yield (TTM)
1.20%Factor Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Outperformer
Somewhat Undervalued
Excellent Quality
Low Price Fluctuation
Analysts are Bearish
Peer Comparison
Peer comparison lists companies from the same sector, scored and ranked based on Factor Analysis. It helps understand how a company stands against its competitors.
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Zydus Lifesciences Ltd.
Zydus Lifesciences Ltd. share price is ₹933.10 as of 05/12/2025, 2:41:48 pm. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
Zydus Lifesciences Ltd. reported an ROE of 20.67 for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Zydus Lifesciences Ltd., Promoter held 75.00%, the FII held 7.30%, DII held 10.90%, and the public held 6.80% of the total shares.
You can easily buy shares of Zydus Lifesciences Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
The fair value of Zydus Lifesciences Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages1
Bearish Moving Averages15
5 Day
938.5010 Day
935.0020 Day
937.1030 Day
954.1050 Day
970.70100 Day
980.50150 Day
967.40200 Day
947.30Indicators
RSI (14)
42.25MACD (12, 26)
-10.00MACD Signal Line (9)
-12.61MFI (14)
62.61ATR (14)
15.98ADX (14)
14.28ROC (21)
-3.70ROC (125)
-2.09Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
